Project Grant R01AG085320
Award Date
2/1/25
Completion Date
1/31/30
Dollars Obligated
$857K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award of $2,493,521 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research investigating the relationship between gut microbiota, vitamin D deficiency, inflammation, and the risk of Alzheimer's disease and related dementias (ADRD) in older adults with and without chronic HIV infection. The primary objectives are to: 1) quantify the independent associations between gut dysbiosis, vitamin D deficiency, and ADRD risk; 2) test whether...
This $849,904 federal Project Grant award from the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research) will fund a research study titled "miRNAs in the Gut-Brain Axis to Predict the Risk of Cognitive Decline in Older Adults" at the University of South Florida. The study aims to determine unique signatures of gut-derived microRNAs (miRNAs) in the blood of older adults with mild cognitive impairment (MCI) and dementia, and investigate how these...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Wisconsin-Madison for $1,102,206 will fund research to characterize the relationship between the gut microbiome and the aging brain, with a focus on Alzheimer's disease and other neurodegenerative conditions. The key components of the project include: Developing specialized transformer-based machine learning models to analyze associations between gut microbiome composition and...
This $630,905 project grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will explore the role of the gut microbiome-derived metabolite imidazole propionate (IMP) in the progression of Alzheimer's disease (AD) and related dementias (ADRD). The project will characterize the relationship between IMP, blood-brain barrier disruption, and AD pathology in mouse models. It will also leverage existing data to determine the association between IMP, fluid AD biomarkers, and...
The federal Project Grant award R61AG089049, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to assess cost and non-cost barriers to the use of novel Alzheimer's disease (AD) and related dementia (ADRD) therapeutics among older Hispanic or Latino adults. The project will involve semi-structured interviews with a cohort of Latino adults and Latino patients with AD/ADRD and their caregivers, followed by a population-based survey to systematically capture the...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $825,135 supports research to examine the relationship between gut microbiome-related metabolites, cerebrovascular small vessel disease, and cognitive impairment. The award, granted to The General Hospital Corporation (doing business as Massachusetts General Hospital), aims to: Investigate the association between gut microbiome metabolites and cerebrovascular small vessel disease...
This Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), is funding the development of neuroprotective engineered bacteria as a therapeutic approach for Alzheimer's disease (AD). The $906,019 grant, awarded on September 25, 2024, will support Bloom Science, Inc., a minority-owned and woman-owned small business, in three key aims: Validating the efficacy of a cocktail of anti-inflammatory compounds (butyrate, beta-hydroxybutyrate, and...
The University of South Florida received a $3,385,215 Project Grant award from the National Institute on Aging, part of the National Institutes of Health within the Department of Health and Human Services. The grant was awarded under the Aging Research program (CFDA 93.866) to fund research titled "Microbial Therapy Improves Gut Permeability to Reduce Cognitive Decline and Alzheimer's Disease." The grant will support research from August 2021 through July 2024 to study the impact of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) seeks to examine the role of the "exposome" as a risk factor for Alzheimer's disease (AD) among non-Hispanic whites, African Americans, and Mexican Americans. The $1,205,827 project, awarded on August 1, 2024, will utilize blood samples from 3,000 participants in the ongoing Health & Aging Brain Study - Health Disparities Study. The goal is to identify environmental exposures that may...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $550,627 to the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the role of oral microbially induced exosomes in the pathogenesis of Alzheimer's disease and related dementias (ADRD). The key objectives of this 5-year research project, with an expected completion date of November 30, 2029, are to determine how exosomes released from...